Comprehensive Analysis of the Fibromyalgia Treatment Market 2025-2034: Growth Rates, Trends, and Future Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the Fibromyalgia Treatment market grown in recent years?
The market size for fibromyalgia treatment has seen steady growth in the recent years. Projected to rise from $2.79 billion in 2024 to $2.9 billion in the following year, it presents a compound annual growth rate (CAGR) of 3.9%. This progression during the historic period is tied to a growing number of fibromyalgia cases, increased public awareness about the condition, various government interventions, and an upsurge in disposable incomes.
How is the fibromyalgia treatment market size expected to evolve during the forecast period?
Expectations for the fibromyalgia treatment market size indicate a consistent expansion in the ensuing years. This market is projected to reach $3.45 billion by 2029, with a compound annual growth rate (CAGR) of 4.5%. The projected growth during this period is linked to factors such as a rising aging population, increases in healthcare spending, escalating incidences of musculoskeletal diseases, and enhanced research and development efforts to improve treatment solutions. Notable trends throughout the forecast period include advancements in therapeutic choices, strategic partnerships, progressive technology integration, and the emergence of innovative treatments.
Get your fibromyalgia treatment market report here!
https://www.thebusinessresearchcompany.com/report/fibromyalgia-treatment-global-market-report
Which key drivers are propelling the fibromyalgia treatment market’s growth?
Government measures specifically targeting musculoskeletal disorders are anticipated to fuel future growth in the fibromyalgia market. These initiatives, which can range from policies and programs to specialized projects, are designed by governments to meet the varying needs of their citizens, stimulate economic growth, enhance the quality of public services, and achieve specific objectives that are in the nation’s interest. Top governing bodies are focusing on these initiatives to deliver necessary aid to those afflicted with musculoskeletal conditions. Musculoskeletal Australia, an Australian organization, reported in 2022 that the nation’s government launched the Own Your Health initiative, a program dedicated to promoting self-care for people suffering from musculoskeletal illnesses for the next quadrennial. Thus, the fibromyalgia market benefits from these increasing government interventions on musculoskeletal disorders. An increase in the elderly population is anticipated to accelerate the growth of the fibromyalgia treatment market. This refers to the rise in the percentage of old age people in a particular society or population, a demographic trend. Treating fibromyalgia becomes increasingly essential for older individuals, as they are more prone to develop fibromyalgia, and their symptoms are usually harsher due to factors related to aging. The United Nations Department of Economic and Social Affairs, a US-based entity, noted in July 2022 that the percentage of people on a global scale who are 65 years old or more is projected to climb from 10% in 2022 to 16% in 2050. Therefore, an increase in the older population spurs the growth of the fibromyalgia treatment market.
What are the market segments in the fibromyalgia treatment industry?
The fibromyalgia treatment market covered in this report is segmented –
1) By Type: Symptomatic Treatment, Targeted Treatment
2) By Drug Class: Antidepressants, Antiepileptics, Muscle Relaxants, Analgesics, Other Drugs
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
Subsegments:
1) By Symptomatic Treatment: Pain Relievers, Antidepressants, Anti-seizure Medications, Sleep Aids, Physical Therapy
2) By Targeted Treatment: Cognitive Behavioral Therapy (CBT), Lifestyle Modifications, Complementary Therapies, Medications Targeting Specific Symptoms
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12933&type=smp
Which leading companies are shaping the growth of the fibromyalgia treatment market?
Major companies operating in the fibromyalgia treatment market are Pfizer Inc., Johnson and Johnson Services Inc., Roche Holding AG, AbbVie Inc., Novartis AG, Sanofi S.A., AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Astellas Pharma Inc., Biogen Inc., Daiichi Sankyo Co. Ltd., Boehringer Ingelheim International GmbH, Sun Pharmaceutical Industries Ltd., Horizon Therapeutics PLC, Endo International PLC, Amneal Pharmaceuticals Inc., Zydus Lifesciences Limited, Lupin Limited.
What key trends are currently impacting the fibromyalgia treatment market’s development?
The key players within the fibromyalgia treatment market are prioritizing the development of cutting-edge solutions, such as microchip technology, to maintain their market share. This unique microchip technology uses a chip to deliver accurate, targeted nerve stimulation to alleviate fibromyalgia symptoms. For example, in November 2022, NeuroMetrix Inc., an American medical equipment manufacturer, introduced the Quell Fibromyalgia device via the Pathfinder Program, providing an innovative solution for reducing fibromyalgia symptoms. Authorized by the U.S Food and Drug Administration (FDA) as the first and only medical device to alleviate fibromyalgia symptoms, the Quell Fibromyalgia uses transcutaneous electrical nerve stimulation (TENS). This device, powered by proprietary microchip technology, provides precise, high-power nerve stimulation in a small, wearable form, optimized through position and motion sensing.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12933
Which geographic areas are influencing the growth of the fibromyalgia treatment market?
North America was the largest region in the fibromyalgia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in fibromyalgia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Browse Through More Similar Reports By The Business Research Company:
Brain And Neuroimaging Devices Global Market Report 2024
Interventional Neurology Devices And Equipment Global Market Report 2024
Central Nervous System Biomarkers Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
